Respiri Limited

RSH

AU000000RSH4

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. Other stock markets 01:38:41 2024-05-31 EDT			5-day change	1st Jan Change
0.028 ^AUD	-15.15%		-6.67%	-6.67%

05-09	Transcript : Respiri Limited - Special Call
04-30	Respiri to Raise AU$1.6 Million via Placement	MT

Respiri Limited Announces Resignation of Mario Gattino as a Director

November 24, 2019 at 10:57 pm

Respiri Limited advised that Mario Gattino has resigned as a Director of the Company.

Latest news about Respiri Limited

Transcript : Respiri Limited - Special Call	05-08
Respiri to Raise AU$1.6 Million via Placement	04-30	MT
Respiri Partners with Hawaii Independent Physician Association for Remote Patient Monitoring Program; Shares Up 3%	04-28	MT
Transcript : Respiri Limited - Shareholder/Analyst Call	04-17
Respiri Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-28	CI
Respiri Limited Announces Executive Changes	01-28	CI
Respiri Signs Deal to Integrate Echo IQ’s Cardiovascular Technology to Remote Monitoring System; Shares Fall 4%	01-24	MT
Respiri Limited Appoints Tom Takubo as Non-Executive Director	12-13	CI
Transcript : Respiri Limited - Shareholder/Analyst Call	11-14
Respiri Limited Announces Resignation of Brian Leedman as Non-Executive Director	11-03	CI
Respiri Limited Secures Two Additional Healthcare Provider Contract	23-09-28	CI
Australian Bourse Halts Trading in Respiri’s Securities	23-09-14	MT
Respiri Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-31	CI
Transcript : Respiri Limited - Special Call	23-08-30
Respiri Completes Access Manages Services Acquisition	23-08-14	MT
Respiri Completes AU$3 Million Share Purchase Plan	23-08-08	MT
Transcript : Respiri Limited - Shareholder/Analyst Call	23-08-07
Respiri Extends Closing Date of Share Purchase Plan	23-07-25	MT
Respiri Signs Marketing Agreement for Wheezo Device with Fi-Med Management	23-07-10	MT
Transcript : Access Managed Services LLC, Respiri Limited - M&A Call	23-06-06
Respiri Limited Appoints Brian Leedman as Non-Executive Director	23-05-23	CI
Respiri Appoints Chief Commercial Officer for US Market	23-04-12	MT
Respiri Limited Appoints William Sigsbee as Chief Commercial Officer for the US Market	23-04-11	CI
Transcript : Respiri Limited - Special Call	23-03-27
Respiri Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-27	CI

Respiri Limited is an Australia-based e-health software as a service company that supports respiratory health management. It is engaged in research, development and commercialization of medical devices, and the development of mobile health applications. Its Wheezo technology is a breath sensor (medical device) that works with the respiri mobile applications (patient user interface) to record and track wheeze. Wheezo is a smart device to help improve asthma management by monitoring wheeze and documenting symptoms, signs, triggers, weather conditions and medication use. The asthma management platform also facilitates the sharing of data with caregivers, physicians and other health care professionals. Wheezo is used to detect and record abnormal breath sounds (continuous adventitious breath sounds) in the windpipe (trachea), reported as WheezeRate in adults and children for more than two years. It also offers connected care solutions for management of people living with chronic diseases.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-27 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
RESPIRI LIMITED	-6.67%	19.7M
THERMO FISHER SCIENTIFIC	+7.01%	217B
DANAHER CORPORATION	+11.01%	190B
INTUITIVE SURGICAL, INC.	+19.20%	143B
BOSTON SCIENTIFIC CORPORATION	+30.79%	111B
SIEMENS HEALTHINEERS AG	+1.48%	64.59B
EDWARDS LIFESCIENCES CORPORATION	+13.95%	52.36B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.16%	48.45B
AGILENT TECHNOLOGIES, INC.	-6.20%	38.03B
GE HEALTHCARE TECHNOLOGIES INC.	+0.91%	35.61B

Other Advanced Medical Equipment & Technology

Respiri Limited

Equities

RSH

AU000000RSH4

Advanced Medical Equipment & Technology

Respiri Limited Announces Resignation of Mario Gattino as a Director

Latest news about Respiri Limited

Chart Respiri Limited

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Other Advanced Medical Equipment & Technology